Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Reznik

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Nature Metabolism|April 9, 2021
Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNAAlexander N Gorelick, Minsoo Kim, Walid K Chatila, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Obesity shapes selection for driver mutations in cancerCerise Tang, Venise Jan Castillon, Michele Waters, et al.
Urologic Oncology|November 13, 2024
Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitorsSari Khaleel, Marlon Perera, Nathan Papa, et al.
Nature Metabolism|June 19, 2023
A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariationElisa Benedetti, Eric Minwei Liu, Cerise Tang, et al.
Frontiers in Oncology|July 15, 2022
Molecular Characterization of the Tumor Microenvironment in Renal Medullary CarcinomaDavid S Tourigny, Mark Zucker, Minsoo Kim, et al.
Elife|February 23, 2016
Mitochondrial DNA copy number variation across human cancersEd Reznik, Martin L Miller, Yasin Şenbabaoğlu, et al.
Plos One|July 21, 2017
Benign and tumor parenchyma metabolomic profiles affect compensatory renal growth in renal cell carcinoma surgical patientsBarak Rosenzweig, Nimrod D Rubinstein, Ed Reznik, et al.
Clinical Genitourinary Cancer|December 3, 2025
Clinical Management of Synchronous and Metachronous Renal Lesions in Patients With Oncocytoma Treated With Nephrectomy: A 30-Year Single-Center ExperienceLennert Eismann, Stephen W Reese, Mark T Dawidek, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2018
Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinomaCarmen Priolo, Damir Khabibullin, Ed Reznik, et al.
Urology Practice|March 14, 2025
Tumors in Solitary Kidneys Are Not All Equal: Outcomes of Partial Nephrectomy in High-Risk CasesMark T Dawidek, Lina Posada Calderon, Juan Sebastian Arroyave Villada, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Nature Metabolism|April 9, 2021
Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNAAlexander N Gorelick, Minsoo Kim, Walid K Chatila, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Obesity shapes selection for driver mutations in cancerCerise Tang, Venise Jan Castillon, Michele Waters, et al.
Urologic Oncology|November 13, 2024
Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitorsSari Khaleel, Marlon Perera, Nathan Papa, et al.
Nature Metabolism|June 19, 2023
A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariationElisa Benedetti, Eric Minwei Liu, Cerise Tang, et al.
Frontiers in Oncology|July 15, 2022
Molecular Characterization of the Tumor Microenvironment in Renal Medullary CarcinomaDavid S Tourigny, Mark Zucker, Minsoo Kim, et al.
Elife|February 23, 2016
Mitochondrial DNA copy number variation across human cancersEd Reznik, Martin L Miller, Yasin Şenbabaoğlu, et al.
Plos One|July 21, 2017
Benign and tumor parenchyma metabolomic profiles affect compensatory renal growth in renal cell carcinoma surgical patientsBarak Rosenzweig, Nimrod D Rubinstein, Ed Reznik, et al.
Clinical Genitourinary Cancer|December 3, 2025
Clinical Management of Synchronous and Metachronous Renal Lesions in Patients With Oncocytoma Treated With Nephrectomy: A 30-Year Single-Center ExperienceLennert Eismann, Stephen W Reese, Mark T Dawidek, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2018
Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinomaCarmen Priolo, Damir Khabibullin, Ed Reznik, et al.
Urology Practice|March 14, 2025
Tumors in Solitary Kidneys Are Not All Equal: Outcomes of Partial Nephrectomy in High-Risk CasesMark T Dawidek, Lina Posada Calderon, Juan Sebastian Arroyave Villada, et al.
Pageof 11